165 related articles for article (PubMed ID: 10857913)
1. Synthesis, X-ray structure, and anti-leukemic activity of oxovanadium(IV) complexes.
Dong Y; Narla RK; Sudbeck E; Uckun FM
J Inorg Biochem; 2000 Mar; 78(4):321-30. PubMed ID: 10857913
[TBL] [Abstract][Full Text] [Related]
2. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent.
Narla RK; Dong Y; D'Cruz OJ; Navara C; Uckun FM
Clin Cancer Res; 2000 Apr; 6(4):1546-56. PubMed ID: 10778988
[TBL] [Abstract][Full Text] [Related]
3. Spermicidal activity of oxovanadium(IV) complexes of 1, 10-phenanthroline, 2,2'-bipyridyl, 5'-bromo-2'-hydroxyacetophenone and derivatives in humans.
D'Cruz OJ; Dong Y; Uckun FM
Biol Reprod; 1999 Feb; 60(2):435-44. PubMed ID: 9916012
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis-inducing oxovanadium(IV) complexes of 1,10-phenanthroline against human ovarian cancer.
D'Cruz OJ; Dong Y; Uckun FM
Anticancer Drugs; 2000 Nov; 11(10):849-58. PubMed ID: 11142693
[TBL] [Abstract][Full Text] [Related]
5. In vivo antitumor activity of bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) (METVAN [VO(SO4)(Me2-Phen)2]).
Narla RK; Chen CL; Dong Y; Uckun FM
Clin Cancer Res; 2001 Jul; 7(7):2124-33. PubMed ID: 11448932
[TBL] [Abstract][Full Text] [Related]
6. Bis(4,7-dimethyl and 5-dinitro-1,10-phenanthroline) sulfato-oxovanadium(IV)-mediated in vivo male germ cell apoptosis.
D'Cruz OJ; Uckun FM
J Appl Toxicol; 2001; 21(4):331-9. PubMed ID: 11481668
[TBL] [Abstract][Full Text] [Related]
7. Photocytotoxicity and DNA cleavage activity of L-arg and L-lys Schiff base oxovanadium(IV) complexes having phenanthroline bases.
Sasmal PK; Majumdar R; Dighe RR; Chakravarty AR
Dalton Trans; 2010 Aug; 39(30):7104-13. PubMed ID: 20563340
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis inducing novel anti-leukemic agent, bis(4,7-dimethyl-1,10 phenanthroline) sulfatooxovanadium(IV) [VO(SO4)(Me2-Phen)2] depolarizes mitochondrial membranes.
Narla RK; Dong Y; Uckun FM
Leuk Lymphoma; 2001 May; 41(5-6):625-34. PubMed ID: 11378580
[TBL] [Abstract][Full Text] [Related]
9. Metvan: a novel oxovanadium(IV) complex with broad spectrum anticancer activity.
D'Cruz OJ; Uckun FM
Expert Opin Investig Drugs; 2002 Dec; 11(12):1829-36. PubMed ID: 12457442
[TBL] [Abstract][Full Text] [Related]
10. Photocytotoxic oxovanadium(IV) complexes showing light-induced DNA and protein cleavage activity.
Sasmal PK; Saha S; Majumdar R; Dighe RR; Chakravarty AR
Inorg Chem; 2010 Feb; 49(3):849-59. PubMed ID: 20039725
[TBL] [Abstract][Full Text] [Related]
11. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(I.V.) as a novel antileukemic agent with matrix metalloproteinase inhibitory activity.
Narla RK; Dong Y; Klis D; Uckun FM
Clin Cancer Res; 2001 Apr; 7(4):1094-101. PubMed ID: 11309362
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterisation, reactivity and in vitro antiamoebic activity of hydrazone based oxovanadium(IV), oxovanadium(V) and mu-bis(oxo)bis{oxovanadium(V)} complexes.
Maurya MR; Agarwal S; Abid M; Azam A; Bader C; Ebel M; Rehder D
Dalton Trans; 2006 Feb; (7):937-47. PubMed ID: 16462954
[TBL] [Abstract][Full Text] [Related]
13. Solid-state coordination chemistry: structural influences of copper-phenanthroline subunits on oxovanadium organophosphonate phases. hydrothermal synthesis and structural characterization of the two-dimensional materials [Cu(phen)(VO)(O3PCH2PO3)(H2O)], [[Cu(phen)]2(V2O5)(O3PCH2CH2PO3)], and [[Cu(phen)]2(V3O5)(O3PCH2CH2CH2PO3)2(H2O)] and the three-dimensional phase [[Cu(phen)]2(V3O5)(O3PCH2PO3)2(H2O)].
Finn RC; Lam R; Greedan JE; Zubieta J
Inorg Chem; 2001 Jul; 40(15):3745-54. PubMed ID: 11442373
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structure, DNA binding and DNA cleavage activity of oxovanadium(IV) N-salicylidene-S-methyldithiocarbazate complexes of phenanthroline bases.
Sasmal PK; Patra AK; Chakravarty AR
J Inorg Biochem; 2008 Jul; 102(7):1463-72. PubMed ID: 18279964
[TBL] [Abstract][Full Text] [Related]
15. DNA cleavage by new oxovanadium(IV) complexes of N-salicylidene alpha-amino acids and phenanthroline bases in the photodynamic therapy window.
Sasmal PK; Patra AK; Nethaji M; Chakravarty AR
Inorg Chem; 2007 Dec; 46(26):11112-21. PubMed ID: 18020327
[TBL] [Abstract][Full Text] [Related]
16. Oxovanadium(IV) complexes of phenanthroline bases: the dipyridophenazine complex as a near-IR photocytotoxic agent.
Sasmal PK; Saha S; Majumdar R; De S; Dighe RR; Chakravarty AR
Dalton Trans; 2010 Feb; 39(8):2147-58. PubMed ID: 20148235
[TBL] [Abstract][Full Text] [Related]
17. Complexes of cis-dioxomolybdenum(VI) and oxovanadium(IV) with a tridentate ONS donor ligand: synthesis, spectroscopic properties, X-ray crystal structure and catalytic activity.
Fayed AM; Elsayed SA; El-Hendawy AM; Mostafa MR
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Aug; 129():293-302. PubMed ID: 24747851
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, in vitro cytotoxicity, and structure-activity relationships (SAR) of multidentate oxidovanadium(iv) complexes as anticancer agents.
Ni L; Zhao H; Tao L; Li X; Zhou Z; Sun Y; Chen C; Wei D; Liu Y; Diao G
Dalton Trans; 2018 Jul; 47(30):10035-10045. PubMed ID: 29974097
[TBL] [Abstract][Full Text] [Related]
19. DNA binding, antitumor activities, and hydroxyl radical scavenging properties of novel oxovanadium (IV) complexes with substituted isoniazid.
Liao X; Lu J; Ying P; Zhao P; Bai Y; Li W; Liu M
J Biol Inorg Chem; 2013 Dec; 18(8):975-84. PubMed ID: 24077688
[TBL] [Abstract][Full Text] [Related]
20. Remarkable enhancement in photocytotoxicity and hydrolytic stability of curcumin on binding to an oxovanadium(IV) moiety.
Banerjee S; Pant I; Khan I; Prasad P; Hussain A; Kondaiah P; Chakravarty AR
Dalton Trans; 2015 Mar; 44(9):4108-22. PubMed ID: 25623080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
